The anti-proliferative effects of tyrosine kinase inhibitors towards tamoxifen-sensitive and tamoxifen-resistant human breast cancer cell lines in relation to the expression of epidermal growth factor receptors (EGF-R) and the inhibition of EGF-R tyrosine kinase

This publication has 13 references indexed in Scilit:

• A Specific Inhibitor of the Epidermal Growth Factor Receptor Tyrosine Kinase
  Science, 1994
• Epidermal growth factor receptor (EGFr) as a marker for poor prognosis in node-negative breast cancer patients: Neu and tamoxifen failure
  The Journal of Steroid Biochemistry and Molecular Biology, 1990
• Signal transduction by receptors with tyrosine kinase activity
  Published by Elsevier ,1990
• High progesterone receptor concentration in a variant of the ZR-75-1 human breast cancer cell line adapted to growth in oestrogen free conditions
  British Journal of Cancer, 1990
• Inhibition of epidermal growth factor‐induced DNA synthesis by tyrosine kinase inhibitors
  FEBS Letters, 1990
• The Epidermal Growth Factor Family
  Published by Springer Nature ,1990
• Isolation of a Novel Tyrosine Kinase Inhibitor, Lavendustin A, from Streptomyces griseolavendus
  Journal of Natural Products, 1989
• Characterisation of a tamoxifen-resistant variant of the ZR-75-1 human breast cancer cell line (ZR-75-9a1) and stability of the resistant phenotype
  British Journal of Cancer, 1989
• Inhibition of tyrosine protein kinase activity by synthetic isoflavones and flavones.
  The Journal of Antibiotics, 1989
• Epidermal Growth Factor Receptor Gene Expression in Estrogen Receptor-Positive and Negative Human Breast Cancer Cell Lines
  Molecular Endocrinology, 1987